The Relationship Between Upper Extremity Function and Balance and Functional Mobility in Parkinson's Disease
Recruiting
Observational Study
Parkinson Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 26 (estimated)
- Sponsor
- Gazi University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Parkinson's Disease (PD) is the second most common neurodegenerative disease, affecting 2-3% of the population aged 65 and over, characterized by the loss of dopaminergic neurons. The basal ganglia play a significant role in the pathogenesis of PD. The lesions of the basal ganglia impair the ability of patients to perform complex, goal-oriented, and skill-requiring movements. Consequently, motor s…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Having accepted participation in the study after being provided with detailed information about the research
* Having been diagnosed with only Parkinson's Disease by a specialist physician
* Having a Standardized Mini-Mental Test score greater than 24
* Being in stages 1 to 3 …
Contacts